首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
3.
4.
5.
The acute effect of a hypoglycaemic dose of 0.5 U/100 g BW insulin administered intramuscularly on calcium metabolism was investigated in fasted alloxan-treated rats. It was found that the hypercalcaemic effect of insulin was evident only in thyroparathyroidectomized (TPTX) and not in parathyroidectomized (PTX) rats. A subcutaneous administration of 180 MRC mU/100 g BW calcitonin abolished the calcium raising effect of insulin in TPTX rats suggesting a protective role of calcitonin against insulin action in intact rats. In an attempt to elucidate the mechanism of the calcium raising effect of insulin 45Ca administered intravenously was used to indicate the movement of calcium from the plasma pool. Insulin administration delayed the plasma 45Ca disappearance rate but had no effect on bone 45Ca uptake within 120 min. In contrast, insulin administration resulted in a 31% reduction of urinary 45Ca excretion while the urine volume remained unchanged. However, the insulin-induced reduction of urinary calcium excretion could not totally account for the calcium raising effect of insulin in TPTX animals.  相似文献   

6.
For the purposes of this review, the vast and increasingly complex subject of hypercalcemic disorders can be broken down into the following categories: (1) Physiochemical state of calcium in circulation. (2) Pathophysiological basis of hypercalcemia. (3) Causes of hypercalcemia encountered in clinical practice: causes indicated by experience at the University of California, Los Angeles; neoplasia; hyperparathyroidism; nonparathyroid endocrinopathies; pharmacological agents; possible increased sensitivity to vitamin D; miscellaneous causes. (4) Clinical manifestations and diagnostic considerations of hypercalcemic disorders. (5) The management of hypercalcemic disorders: general measures; measures for lowering serum calcium concentration; measures for correcting primary causes—the management of asymptomatic hyperparathyroidism.  相似文献   

7.
Uric acid nephrolithiasis (UAN) is a common disease with an established genetic component that presents a complex mode of inheritance. While studying an ancient founder population in Talana, a village in Sardinia, we recently identified a susceptibility locus of approximately 2.5 cM for UAN on 10q21-q22 in a relatively small sample that was carefully selected through genealogical information. To refine the critical region and to identify the susceptibility gene, we extended our analysis to severely affected subjects from the same village. We confirm the involvement of this region in UAN through identical-by-descent sharing and autozygosity mapping, and we refine the critical region to an interval of approximately 67 kb associated with UAN by linkage-disequilibrium mapping. After inspecting the genomic sequences available in public databases, we determined that a novel gene overlaps this interval. This gene is divided into 15 exons, spanning a region of approximately 300 kb and generating at least four different proteins (407, 333, 462, and 216 amino acids). Interestingly, the last isoform was completely included in the 67-kb associated interval. Computer-assisted analysis of this isoform revealed at least one membrane-spanning domain and several N- and O-glycosylation consensus sites at N-termini, suggesting that it could be an integral membrane protein. Mutational analysis shows that a coding nucleotide variant (Ala62Thr), causing a missense in exon 12, is in strong association with UAN (P=.0051). Moreover, Ala62Thr modifies predicted protein secondary structure, suggesting that it may have a role in UAN etiology. The present study underscores the value of our small, genealogically well-characterized, isolated population as a model for the identification of susceptibility genes underlying complex diseases. Indeed, using a relatively small sample of affected and unaffected subjects, we identified a candidate gene for multifactorial UAN.  相似文献   

8.
9.
10.
11.
12.
Commercial food- and pheromone-baited pitfall traps and pheromone-baited sticky traps were used during 2003 to survey stored-product insect adults in eight participating feed mills in the midwestern United States. Across the eight feed mills, 27 species of beetles (Coleoptera) and three species of moths (Lepidoptera) were captured in commercial traps. The red flour beetle, Tribolium castaneum (Herbst), was the most abundant insect species captured inside the eight mills. The warehouse beetle, Trogoderma variabile (Ballion), was the most abundant insect species outside the mill and in the mill load-out area. The Indianmeal moth, Plodia interpunctella (Hübner), was the most abundant moth species inside the mill and in the mill receiving area. The Simpson's index of species diversity among mills ranged from 0.39 (low diversity) to 0.81 (high diversity). The types of species found among mills were different, as indicated by a Morisita's index of <0.7, for the majority of mills. The differences in the types and numbers of insect species captured inside, outside, in receiving, and in load-out areas could be related to differences in the types of animal feeds produced and the degree of sanitation and pest management practiced.  相似文献   

13.
Diminished mitochondrial activities were deemed to play an imperative role in surged oxidative damage perceived in hyperoxaluric renal tissue. Proteomics is particularly valuable to delineate the damaging effects of oxidative stress on mitochondrial proteins. The present study was designed to apply large-scale proteomics to describe systematically how mitochondrial proteins/pathways govern the renal damage and calcium oxalate crystal adhesion in hyperoxaluria. Furthermore, the potential beneficial effects of combinatorial therapy with N-acetylcysteine (NAC) and apocynin were studied to establish its credibility in the modulation of hyperoxaluria-induced alterations in mitochondrial proteins. In an experimental setup with male Wistar rats, five groups were designed for 9?d. At the end of the experiment, 24-h urine was collected and rats were euthanized. Urinary samples were analyzed for kidney injury marker and creatinine clearance. Transmission electron microscopy revealed distorted renal mitochondria in hyperoxaluria but combinatorial therapy restored the normal mitochondrial architecture. Mitochondria were isolated from renal tissue of experimental rats, and mitochondrial membrane potential was analyzed. The two-dimensional electrophoresis (2-DE) based comparative proteomic analysis was performed on proteins isolated from renal mitochondria. The results revealed eight differentially expressed mitochondrial proteins in hyperoxaluric rats, which were identified by Matrix-assisted laser desorption/ionization time of flight/time of flight (MALDI-TOF/TOF) analysis. Identified proteins including those involved in important mitochondrial processes, e.g. antioxidant defense, energy metabolism, and electron transport chain. Therapeutic administration of NAC with apocynin significantly expunged hyperoxaluria-induced discrepancy in the renal mitochondrial proteins, bringing them closer to the controls. The results provide insights to further understand the underlying mechanisms in the development of hyperoxaluria-induced nephrolithiasis and the therapeutic relevance of the combinatorial therapy.  相似文献   

14.
Renal stone disease is an ancient and common affliction, common in industrialised nations. The causes and incidence of nephrolithiasis are presented. Afterwards, the promoters and inhibitors of renal stone formation analysis in urine are described including enzymatic methods, chromatography, capillary electrophoresis and other techniques. Aspects such as sample collection and storage are also included. The review article includes referenced tables that provide summaries of methodology for the analysis of nephrolithiasis related compounds.  相似文献   

15.
16.
We describe a patient who presented with multi-system organ failure due to extreme hypercalcemia (serum calcium 19.8 mg/dL), resulting from primary hyperparathyroidism. He was found to have a 4.8 cm solitary atypical parathyroid adenoma. His course was complicated by complete heart block, acute kidney injury, and significant neurocognitive disturbances. Relevant literature was reviewed and discussed. Hyperparathyroidism-induced hypercalcemic crisis (HIHC) is a rare presentation of primary hyperparathyroidism and only a small minority of these patients develop significant cardiac and renal complications. In cases of HIHC, a multidisciplinary effort can facilitate rapid treatment of life-threatening hypercalcemia and definitive treatment by surgical resection. As such, temporary transvenous cardiac pacing and renal replacement therapy can provide a life-saving bridge to definitive parathyroidectomy in cases of HIHC.  相似文献   

17.
Nephrolithiasis is a common problem associated with significant costs to the health care system. Its prevalence continues to increase, particularly in women, which is attributed to changes in diet and lifestyle. The costs associated with the evaluation and management of nephrolithiasis in the United States has been estimated to be $1.83 billion, and, without any intervention, the risk of recurrence is high. This article reviews the management options for nephrolithiasis including a new formulation of potassium citrate, Urocit®-K 15 mEq, that allows for dosing flexibility which can lead to improved compliance and tolerability.Key words: Nephrolithiasis, Standard metabolic evaluation, Hypercalcuria, Struvite stonesThe incidence of nephrolithiasis worldwide is approximately 1%. In the United States, the prevalence has increased from 3.2% in the 1970s to 5.2% in the 1990s.1 A recent study suggests that the prevalence of stone disease continues to rise, particularly in women, thought to be due to changes in diet and lifestyle.2 The costs associated with the evaluation and management of nephrolithiasis in the United States has been estimated to be $1.83 billion.3 The recurrence rates for stone disease are high. After an initial stone, there is a 30% to 50% chance of forming a second stone within 5 years.Given the high recurrence rate after a first time stone episode, an initial metabolic evaluation to search for underlying causes of nephrolithiasis is warranted. In patients presenting with a single stone episode, a risk assessment should be made to determine the extent of the evaluation (Figure 1). There are a number of factors associated with increased risk of recurrent stone formation (4 Patients with any of these risk factors should be considered at risk and should undergo a standard metabolic evaluation (SME) (Open in a separate windowFigure 1Algorithm for diagnostic evaluation.

Table 1

Risk Factors for Stone Development
  • Family history of stones
  • Bone/gastrointestinal disease
  • Gout
  • Chronic urinary tract infection
  • Nephrocalcinosis
  • Obesity
  • Type II diabetes
  • Large/complex stones
  • Specific stone composition (uric acid or cystine)
Open in a separate window

Table 2

Identification of Metabolic Abnormalities Using Standard Metabolic Evaluation
Urinary FindingImplicated Dietary-Environmental Disturbances
Total volume (TV) < 2 L/dayLow fluid intake, excessive sweating
Sodium (Na) > 200 mEq/daySalt abuse
Oxalate (Ox) > 45 mg/dayIntake of oxalate-rich foods, very low calcium intake
Calcium (Ca) > 250 mg/dayHigh intake of calcium in some cases
Uric acid (UA) > 600 mg/dayHigh animal protein intake
Sulfate (SO4) > 30 mmol/dayExcessive animal protein intake
Citrate < 500 mg/dayHigh intake of animal protein and salt
Open in a separate windowStone formation results from super saturation of urine with stone-forming salts. There are also certain urinary inhibitors that help to prevent salts from crystallizing and forming stones. One of the most potent and important inhibitors of calcium oxalate and uric acid stone formation is citrate. The SME consists of two 24-hour urine collections that are analyzed for urinary abnormalities that contribute to stone formation, such as elevated levels of stone-forming salts or low levels of inhibitors of stone formation. An underlying physiologic or environmental cause for nephrolithiasis can be determined in 97% of cases.Regardless of the underlying metabolic abnormality, certain dietary modifications should be recommended. Patients should be encouraged to increase their fluid intake to greater than 3 L/day to maintain a urine output of at least 2.5 L/day.5 Dietary sodium and oxalate intake should be limited. Patients should also be instructed to minimize consumption of animal proteins. In general, calcium intake should not be restricted even in those with hypercalcuria. The recommendation for patients with hypercalcuria should be a modest calcium intake, approximately 800 mg/day, or 2 to 3 servings of dairy per day.Hypercalcuria is defined as urine calcium greater than 250 mg/day. The most common cause of elevated urine calcium is absorptive hypercalcuria. In patients with an elevated serum calcium and hypercalcuria, a work-up for hyperparathyroidism should be pursued. For patients with modestly elevated urine calcium and elevated urine sodium, a trial of sodium restriction may be offered as an initial treatment. For patients with normal urine sodium or markedly elevated urine calcium, as well as those who fail sodium restriction, pharmacological management with a thiazide diuretic is the treatment of choice. The most common agents used are indapamide 1.25 to 2.5 mg/day or chlorthalidone 25 to 50 mg/day. When using these agents, potassium supplementation should be provided due to the concern for hypokalemia. Potassium citrate (Urocit®-K 15, Mission Pharmacal, San Antonio, TX) is the preferred agent as it will also increase urinary citrate. Typically, a starting dose would be Urocit-K 15 mEq with breakfast and 30 mEq with dinner. For patients with elevated urinary pH (> 6.5), potassium chloride may be substituted for potassium citrate due to a concern of over-alkalization.Elevated urine uric acid levels can cause hyperuricosuric calcium oxalate nephrolithiasis. Hyperuricosuria is defined as urinary uric acid levels greater than 800 mg/day. Patients should be counseled to limit animal protein intake to 6 to 8 oz daily. If the uric acid levels fail to correct with conservative measures, allopurinol 300 mg/day can be prescribed.6 Potassium citrate is an alternative to allopurinol.7 Urocit-K 15 mEq with breakfast and dinner may be useful in patients with modest hyperuricosuria, particularly those with hypocitraturia.Citrate is an important inhibitor of stone formation. It inhibits calcium salt crystallization and raises urinary pH by acting as a buffer. Hypocitraturia, defined as urinary citrate less than 500 mg/day, is a risk factor for calcium nephrolithiasis. Potassium citrate has been demonstrated to reduce the stone formation rates by 96% in patients with hypocitraturia.8 The response to potassium citrate has also been shown to be durable.9 With a median of 41 months follow-up, urinary pH and citrate levels remained significantly higher in patients treated with potassium citrate when compared with pretreatment values. Potassium citrate also significantly decreased the stone formation rate in this long-term clinical trial (Figure 2). The dosage should be titrated with a goal of a urinary citrate level greater than 500 mg/day. Urocit-K has recently been formulated into a 15 mEq tablet, providing greater dosing flexibility and the potential to reduce the total number of tablets required. A reasonable starting dose for modest hypocitraturia would be one Urocit-K 15 mEq with breakfast and dinner. For patients with more significant hypocitraturia, the recommendation is for Urocit-K 15 mEq with breakfast and 30 mEq with dinner.Open in a separate windowFigure 2Stone formation rates pretreatment and posttreatment with potassium citrate.9Idiopathic uric acid nephrolithiasis is commonly associated with gouty diathesis, or low urinary pH. Alkalization of the urine can not only prevent future uric acid stones from forming, but can potentially dissolve existing stones. The goal of alkalization should be a urinary pH between 6.0 and 6.5. This is best achieved with potassium citrate. Urocit-K is usually prescribed with a dose between 15 to 30 mEq with breakfast and dinner. The dose can be titrated to obtain the desired pH. In cases where patients continue to form uric acid stones despite adequate alkalization, or if serum uric acid levels exceed 8 mg/dL, allopurinol 300 mg/day may be added.Potassium citrate has a role in the treatment of cystine stones as well. Patients with cystine stones should be instructed to increase their fluid intake to maintain a urine volume greater than 4 L/day. In addition, potassium citrate should be prescribed to maintain urinary pH between 6.5 and 7.0. The usual dose would be Urocit-K 15 to 30 mEq with breakfast and dinner. Tiopronin (Thiola®, Mission Pharmacal) should be initiated when cystine concentration is greater than 250 mg/L. Thiola is started at 200 mg twice per day. The dose is adjusted to maintain urinary cystine concentrations below 200 mg/L.Infection stones, or struvite stones, are associated with urease-splitting bacteria. Patients often present with recurrent urinary tract infections and large stones. Patients with a stone analysis revealing 100% struvite often do not require a SME. If risk factors are present, or if there is a component of calcium nephrolithiasis on the stone analysis, a SME should be considered. The treatment of infected stones consists of complete stone removal. Patients should also be placed on prophylactic antibiotics. Acetohydroxamic acid (Lithostat®, Mission Pharmacal) is a urease inhibitor that is useful in patients in whom the entire stone cannot be removed or in patients with persistent infection. It is prescribed at a dose of 250 mg twice per day. Any associated metabolic abnormalities found on a SME should be treated appropriately.Nephrolithiasis is a common problem associated with significant costs to the health care system. The prevalence of nephrolithiasis continues to increase. Without any interventions, the risk of recurrence is high. Recurrent stone formers and first-time stone formers with risk factors for recurrence should undergo a SME. An underlying etiology for stone formation can be found in 97% of patients. Once a metabolic abnormality is found, targeted medical therapy can be initiated (Figure 3).10 The majority of medications used to prevent stone recurrence are well tolerated and highly effective. In particular, potassium citrate can reduce stone formation rates by up to 96% and has durable long-term effects. A new formulation of potassium citrate, Urocit-K 15 mEq tablets, increases dosing flexibility leading to improved compliance and tolerability.Open in a separate windowFigure 3Medical management of nephrolithiasis from the ABC’s of Medical Management of Stones.10

Main Points

  • Due to the high recurrence rates after a first-time stone episode, an initial metabolic evaluation to search for the underlying causes of nephrolithiasis is recommended. Risk factors include diabetes or a family history of kidney stones, use of medications such as topiramate and guaifenesin, and obesity.
  • Regardless of the metabolic abnormality, dietary modifications are recommended, as well as increased fluid intake. Patients should limit their sodium and oxalate intake and minimize consumption of animal proteins. Calcium intake should not be restricted.
  • Elevated urine uric acid levels can cause hyperuricosuric calcium oxalate nephrolithiasis. Patients should limit animal protein intake to 6 to 8 oz daily. If uric acid levels fail to correct with conservative measures, allopurinol 300 mg/day can be prescribed. Potassium citrate is also an alternative to allopurinol.
  • Targeted medical therapy can be initiated once a metabolic abnormality is found. Medications used to prevent stone recurrence are well tolerated and highly effective. Potassium citrate can reduce stone formation rates by up to 96% and has durable longterm effects. Urocit-K 15®, a new formulation of potassium citrate, increases dosing flexibility leading to improved compliance and tolerability.
  相似文献   

18.
Calcium nephrolithiasis is one of the most common causes of renal stones. While the prevalence of this disease has increased steadily over the last 3 decades, its pathogenesis is still unclear. Previous studies have indicated that a genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with the total serum calcium levels. In this study, we collected DNA samples from 480 Taiwanese subjects (189 calcium nephrolithiasis patients and 291 controls) for genotyping the CASR gene. Our results indicated no significant association between the CASR polymorphism (rs17251221) and the susceptibility of calcium nephrolithiasis. However, we found a significant association between rs17251221 and stone multiplicity. The risk of stone multiplicity was higher in patients with the GG+GA genotype than in those with the AA genotype (chi-square test:P = 0.008;odds ratio  =  4.79;95% confidence interval, 1.44–15.92;Yates'' correction for chi-square test:P = 0.013). In conclusion, our results provide evidence supporting the genetic effects of CASR on the pathogenesis of calcium nephrolithiasis.  相似文献   

19.
Dictyostelid cellular slime molds (dictyostelids) associated with grassland ecosystems of the central and western United States were investigated at nine sites that included examples of the three major ecological types of grasslands (tall grass, mixed grass and short grass) generally recognized for the region. Samples of soil/humus collected from each site were examined with the Cavender method of isolating dictyostelids. For each of those six sites with well developed gallery forests present, an additional set of forest soil/humus samples was collected. A more intensive sampling effort was carried out at one site (Konza LTER) to assess the possible effects of burning and grazing on dictyostelid diversity and density. Twelve species of dictyostelids were recovered from grassland sites, whereas gallery forest sites yielded only nine species. Four cosmopolitan species (Dictyostelium giganteum, D. mucoroides, D. sphaerocephalum and Polysphondylium pallidum) were represented by the greatest densities of clones, with D. sphaerocephalum particularly common. The general pattern across all sites was that both species richness and density of dictyostelids decreased with decreasing precipitation. Samples collected from ungrazed grassland plots yielded higher numbers of both species and clones as compared to grazed plots, and the general pattern was for both values to increase as the interval between fires increased. For numbers of clones this correlation was statistically significant.  相似文献   

20.
A 35-year-old longleaf pine stand exhibited trees in various stages of decline. A study was conducted to determine root-infecting fungi and other abnormalities associated with varying degrees of crown symptoms. A four-class crown symptom rating system was devised according to ascending symptom severity. Leptographium procerum and L. terebrantis were significantly associated with increasing crown symptom severity. Heterobasidion annosum was also isolated in higher frequency as crown symptoms increased. Also, evidence of insects on roots increased as did amount of resinosis observed. Edaphic and silvicultural factors may interact with these pathogens and insects to pose a pathological limitation on longer-term management objectives. Further research is needed to determine relationships among various edaphic, silvicultural, and biological factors associated with the decline syndrome on this site. This revised version was published online in June 2006 with corrections to the Cover Date.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号